AI Buyer Insights:

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Michelin, an e2open customer evaluated Oracle Transportation Management

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Michelin, an e2open customer evaluated Oracle Transportation Management

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Shanghai Abbott Pharmaceutical Co. Tech Stack and Enterprise Applications

HCM
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
UKG Legacy UKG Great Place to Work Emprising Employee Experience, Employee Engagement HCM n/a 2020 2022
AI-Powered Application
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
YUEMIA Legacy YUEMIA MedChat Chatbots and Conversational AI AI-Powered Application n/a 2016 2016
In 2016 Shanghai Abbott Pharmaceutical Co. deployed YUEMIA MedChat to support medical marketing, physician engagement and patient-education workflows across China. YUEMIA MedChat is a Chatbots and Conversational AI application used to expand digital outreach and help reduce field-marketing costs by automating routine engagement and educational interactions. The implementation centered on the MedChat conversational module, configured to deliver multi-role conversational flows for physicians and patients and to sequence educational content for patient-education workflows. Functional capabilities implemented included automated question and answer handling, scheduled messaging for campaign orchestration, and content management for clinical and promotional materials, aligned with medical marketing use cases. Configuration emphasized role-based content delivery and conversational logic to route inquiries to appropriate follow up channels when needed. Operational coverage spanned national field-marketing teams and digital engagement channels across China, with primary business functions impacted including medical affairs, marketing, and patient support. Governance and process alignment focused on content oversight between medical affairs and marketing to ensure consistent clinical messaging and regulatory compliance. Vendor materials cite outcomes of expanded digital outreach and reduced field-marketing costs as justification for the deployment of YUEMIA MedChat.
Content Management
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Adobe Systems Legacy Adobe Experience Manager Digital Asset Management Content Management n/a 2020 2020
CRM
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Customer Experience CRM 2018 2018
Data Management Platform CRM 2020 2020
Marketing Analytics CRM 2020 2020
Marketing Analytics CRM 2021 2021
Marketing Automation CRM 2018 2018
Tag Management CRM 2020 2020
ITSM
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Application Performance Management ITSM 2022 2022
PaaS
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Master Data Management PaaS 2019 2019
IaaS
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Application Hosting and Computing Services IaaS 2020 2020
Content Delivery Network IaaS 2022 2022
Content Delivery Network IaaS 2022 2022
Content Delivery Network IaaS 2021 2021

IT Decision Makers and Key Stakeholders at Shanghai Abbott Pharmaceutical Co.

First Name Last Name Title Function Department Email Phone
No data found

Apps Being Evaluated by Shanghai Abbott Pharmaceutical Co. Executives

APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Shanghai Abbott Pharmaceutical Co. IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Shanghai Abbott Pharmaceutical Co. digital transformation priorities and AI adoption trends.
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Shanghai Abbott Pharmaceutical Co. Technographics
Shanghai Abbott Pharmaceutical Co. is a Life Sciences organization based in China, with around 80 employees and annual revenues of $8.0 million.
Shanghai Abbott Pharmaceutical Co. operates a diverse technology stack with applications such as UKG Great Place to Work Emprising, YUEMIA MedChat and Adobe Experience Manager, covering areas like Employee Experience, Employee Engagement, Chatbots and Conversational AI and Digital Asset Management.
Shanghai Abbott Pharmaceutical Co. has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as UKG, YUEMIA and Adobe Systems.
Shanghai Abbott Pharmaceutical Co. recently adopted applications including New Relic APM in 2022, Fastly in 2022 and Amazon CloudFront in 2022, highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Shanghai Abbott Pharmaceutical Co.’s key decision makers and IT executives, available to Premium subscribers.
Our research team continuously updates Shanghai Abbott Pharmaceutical Co.’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Shanghai Abbott Pharmaceutical Co. technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.